566 related articles for article (PubMed ID: 32187157)
1. Distribution and linkage disequilibrium of the enhancer SNP rs5758550 among Latin American populations: influence of continental ancestry.
Elias ABR; Araújo GS; de Souza SJ; Suarez-Kurtz G
Pharmacogenet Genomics; 2020 Jun; 30(4):67-72. PubMed ID: 32187157
[TBL] [Abstract][Full Text] [Related]
2. CYP2D6 haplotypes with enhancer single-nucleotide polymorphism rs5758550 and rs16947 (*2 allele): implications for CYP2D6 genotyping panels.
Ray B; Ozcagli E; Sadee W; Wang D
Pharmacogenet Genomics; 2019 Feb; 29(2):39-47. PubMed ID: 30520769
[TBL] [Abstract][Full Text] [Related]
3. Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activity.
Wang D; Poi MJ; Sun X; Gaedigk A; Leeder JS; Sadee W
Hum Mol Genet; 2014 Jan; 23(1):268-78. PubMed ID: 23985325
[TBL] [Abstract][Full Text] [Related]
4. Population impact of pharmacogenetic tests in admixed populations across the Americas.
Suarez-Kurtz G
Pharmacogenomics J; 2021 Apr; 21(2):216-221. PubMed ID: 33110249
[TBL] [Abstract][Full Text] [Related]
5. An ancestry informative marker panel design for individual ancestry estimation of Hispanic population using whole exome sequencing data.
Wang LJ; Zhang CW; Su SC; Chen HH; Chiu YC; Lai Z; Bouamar H; Ramirez AG; Cigarroa FG; Sun LZ; Chen Y
BMC Genomics; 2019 Dec; 20(Suppl 12):1007. PubMed ID: 31888480
[TBL] [Abstract][Full Text] [Related]
6. VKORC1 polymorphisms in Brazilians: comparison with the Portuguese and Portuguese-speaking Africans and pharmacogenetic implications.
Suarez-Kurtz G; Amorim A; Damasceno A; Hutz MH; de Moraes MO; Ojopi EB; Pena SD; Perini JA; Prata MJ; Ribeiro-dos-Santos A; Romano-Silva MA; Teixeira D; Struchiner CJ
Pharmacogenomics; 2010 Sep; 11(9):1257-67. PubMed ID: 20860466
[TBL] [Abstract][Full Text] [Related]
7. From Croatian Roma to 1000 Genomes: The Story of the
Stojanović Marković A; Celinšćak Ž; Šetinc M; Škarić-Jurić T; Peričić Salihović M; Zajc Petranović M
J Pers Med; 2022 Aug; 12(8):. PubMed ID: 36013302
[TBL] [Abstract][Full Text] [Related]
8. Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.
Suarez-Kurtz G; Genro JP; de Moraes MO; Ojopi EB; Pena SD; Perini JA; Ribeiro-dos-Santos A; Romano-Silva MA; Santana I; Struchiner CJ
Pharmacogenomics J; 2012 Jun; 12(3):267-76. PubMed ID: 21173785
[TBL] [Abstract][Full Text] [Related]
9. Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans.
Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Sosa-Macías M; Terán E; López-López M; Rodeiro I; Moya GE; Calzadilla LR; Ramírez-Roa R; Grazina M; Estévez-Carrizo FE; Barrantes R; LLerena A;
Clin Pharmacol Ther; 2020 Jan; 107(1):257-268. PubMed ID: 31376146
[TBL] [Abstract][Full Text] [Related]
10. The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity.
Dinh JC; Boone EC; Staggs VS; Pearce RE; Wang WY; Gaedigk R; Leeder JS; Gaedigk A
Clin Pharmacol Ther; 2022 Mar; 111(3):646-654. PubMed ID: 34716917
[TBL] [Abstract][Full Text] [Related]
11. Long-Distance Phasing of a Tentative "Enhancer" Single-Nucleotide Polymorphism With
Boone EC; Wang WY; Gaedigk R; Cherner M; Bérard A; Leeder JS; Miller NA; Gaedigk A
Front Pharmacol; 2020; 11():486. PubMed ID: 32457600
[TBL] [Abstract][Full Text] [Related]
12. Distribution of CYP2D6 alleles and phenotypes in the Brazilian population.
Friedrich DC; Genro JP; Sortica VA; Suarez-Kurtz G; de Moraes ME; Pena SD; dos Santos AK; Romano-Silva MA; Hutz MH
PLoS One; 2014; 9(10):e110691. PubMed ID: 25329392
[TBL] [Abstract][Full Text] [Related]
13. Ancestral components of admixed genomes in a Mexican cohort.
Johnson NA; Coram MA; Shriver MD; Romieu I; Barsh GS; London SJ; Tang H
PLoS Genet; 2011 Dec; 7(12):e1002410. PubMed ID: 22194699
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of CYP2D6 enhancer polymorphisms.
Wang D; Papp AC; Sun X
Hum Mol Genet; 2015 Mar; 24(6):1556-62. PubMed ID: 25381333
[TBL] [Abstract][Full Text] [Related]
15. A multi-ancestry genome-wide association study in type 1 diabetes.
Michalek DA; Tern C; Zhou W; Robertson CC; Farber E; Campolieto P; Chen WM; Onengut-Gumuscu S; Rich SS
Hum Mol Genet; 2024 May; 33(11):958-968. PubMed ID: 38453145
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations.
Suarez-Kurtz G; Struchiner CJ
Pharmacogenomics; 2024 Mar; 25(4):187-195. PubMed ID: 38506326
[TBL] [Abstract][Full Text] [Related]
17. Global pharmacogenomics: distribution of CYP3A5 polymorphisms and phenotypes in the Brazilian population.
Suarez-Kurtz G; Vargens DD; Santoro AB; Hutz MH; de Moraes ME; Pena SD; Ribeiro-dos-Santos Â; Romano-Silva MA; Struchiner CJ
PLoS One; 2014; 9(1):e83472. PubMed ID: 24427273
[TBL] [Abstract][Full Text] [Related]
18. Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population.
Céspedes-Garro C; Rodrigues-Soares F; Jiménez-Arce G; Naranjo MG; Tarazona-Santos E; Fariñas H; Barrantes R; Llerena A;
Rev Biol Trop; 2016 Sep; 64(3):1067-76. PubMed ID: 29461783
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-8 genetic diversity, haplotype structure and production differ in two ethnically distinct South African populations.
Paximadis M; Picton ACP; Sengupta D; Ramsay M; Puren A; Tiemessen CT
Cytokine; 2021 Jul; 143():155489. PubMed ID: 33814271
[TBL] [Abstract][Full Text] [Related]
20. Molecular diversity at the CYP2D6 locus in healthy and schizophrenic southern Brazilians.
Kohlrausch FB; Gama CS; Lobato MI; Belmonte-de-Abreu P; Gesteira A; Barros F; Carracedo A; Hutz MH
Pharmacogenomics; 2009 Sep; 10(9):1457-66. PubMed ID: 19761369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
